• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Election 2025
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Election 2025
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags FDA

    Tag: FDA

    A sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020.  Shares of Merck and Moderna jumped early Tuesday, Dec. 13, 2022,  after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study.
    Healthcare

    FDA grants expedited review for Moderna RSV vaccine for 60 and older

    Abigail Adcox -
    January 30, 2023 3:34 pm
    0
    FDA to relax blood donation rules for gay and bisexual men in monogamous relationships
    News

    FDA to relax blood donation rules for gay and bisexual men in monogamous relationships

    Abigail Adcox -
    January 27, 2023 3:00 pm
    0
    President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File)
    News

    FDA advisory panel recommends using bivalent COVID-19 shots for all doses

    Abigail Adcox -
    January 26, 2023 10:21 pm
    0
    Boxes of the drug mifepristone line a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., on Wednesday, March 16, 2022.
    News

    Lawsuit says West Virginia ban on abortion drugs is illegal due to FDA approval

    Abigail Adcox -
    January 25, 2023 3:49 pm
    0
    FDA proposes shifting to annual COVID-19 boosters targeted at newest strains
    News

    FDA proposes shifting to annual COVID-19 boosters targeted at newest strains

    Abigail Adcox -
    January 23, 2023 4:51 pm
    0
    DOJ investigating Abbott Lab after infant formula shortage
    Healthcare

    DOJ investigating Abbott Lab after infant formula shortage

    Cami Mondeaux -
    January 21, 2023 2:17 pm
    0
    CVS and Walgreens find themselves at the center of the abortion debate
    Healthcare

    CVS and Walgreens find themselves at the center of the abortion debate

    Abigail Adcox -
    January 21, 2023 9:00 am
    0
    CDC and FDA investigating link between Pfizer’s bivalent COVID-19 shot and strokes
    News

    CDC and FDA investigating link between Pfizer’s bivalent COVID-19 shot and strokes

    Abigail Adcox -
    January 13, 2023 9:03 pm
    0
    President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File)
    News

    FDA paused trials for experimental drugs more often in recent years

    Abigail Adcox -
    January 10, 2023 7:40 pm
    0
    President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File)
    Healthcare

    FDA approves new experimental Alzheimer’s drug

    Abigail Adcox -
    January 6, 2023 7:16 pm
    0
    1...363738...180Page 37 of 180
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.